Pillstats
Rx only · Injection, Solution · Intramuscular

Midazolam Hydrochloride

Brands: Midazolam · Midazolam Hydrochloride

14 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US34 NDCs
14 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN05CD08
RxCUI (US)6960
US makers14 labelers
Packages49
DEA / ScheduleCIV

US acquisition costNADAC · per unit

Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.159$0.318$0.478$0.637Feb 2025Feb 2026Jul 2026
$0.554
Latest avg · Jul 22, 2026
+25%
Since Feb 19, 2025
14
Active US suppliers
43%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

31K62K93K123K2025 Q12025 Q22025 Q32025 Q42026 Q1
74K
Rx · 2026 Q1
175K
Units dispensed
-31%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it14 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Hospira, Inc.unknown11SUPPLYING
Fresenius Kabi USA, LLCunknown10SUPPLYING
Somerset Therapeutics, LLCunknown4SUPPLYING
ONESOURCE SPECIALTY PHARMA LIMITEDunknown4SUPPLYING
Gland Pharma Limitedunknown3SUPPLYING
STERISCIENCE SPECIALTIES PRIVATE LIMITEDunknown3SUPPLYING
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.unknown3SUPPLYING
A-S Medication Solutionsunknown3SUPPLYING
Sagent Pharmaceuticalsunknown2SUPPLYING
Henry Schein Inc.unknown2SUPPLYING
Belcher Pharmaceuticals, LLCunknown1SUPPLYING
JVET PHARMACEUTICALS LLCunknown1SUPPLYING
Cardinal Health 107, LLCunknown1SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 2, 2020
    SHORTAGEDrug shortage: Midazolam Hydrochloride Injection (Gland Pharma Limited)

    Midazolam Hydrochloride Injection — reported in shortage by Gland Pharma Limited. Therapeutic category: Anesthesia, Neurology.

  • Apr 2, 2020
    SHORTAGEDrug shortage: Midazolam Hydrochloride Injection (Avet Pharmaceuticals, Inc.)

    Midazolam Hydrochloride Injection — reported in shortage by Avet Pharmaceuticals, Inc.. Therapeutic category: Anesthesia, Neurology.

  • Apr 2, 2020
    SHORTAGEDrug shortage: Midazolam Hydrochloride Injection (Fresenius Kabi USA, LLC)

    Midazolam Hydrochloride Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anesthesia, Neurology.

  • Apr 2, 2020
    SHORTAGEDrug shortage: Midazolam Hydrochloride Injection (Hospira, Inc., a Pfizer Company)

    Midazolam Hydrochloride Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Anesthesia, Neurology.

  • Oct 27, 2017
    RECALLRecall (Class I): Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL (1 mg / mL), 24 X 2mL Prefilled single-use syringes per carton…

    Labeling: Label MIX-UP. Blister Packages, Labeled as Midazolam injection, USP, 2 mg / 2 ml, Containing Syringes of Ondansetron Injection, USP, 4 mg / 2 mL — Recalling firm: Fresenius Kabi USA, LLC — Nationwide in the USA

  • Dec 16, 2016
    RECALLRecall (Class II): MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APP Pharmaceuticals, LLC S…

    Failed Impurities/Degradation Specifications — Recalling firm: Fresenius Kabi USA, LLC — Nationwide and Puerto Rico

  • Sep 27, 2012
    RECALLRecall (Class II): MIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only. APP Pharmaceuticals, LLC. S…

    Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles. — Recalling firm: Fresenius Kabi USA, LLC — U.S. Nationwide Including Puerto Rico